NO143316C - Analogifremgangsmaate til fremstilling av ny oksazolidinoner med farmakodynamiske egenskaper - Google Patents

Analogifremgangsmaate til fremstilling av ny oksazolidinoner med farmakodynamiske egenskaper

Info

Publication number
NO143316C
NO143316C NO762928A NO762928A NO143316C NO 143316 C NO143316 C NO 143316C NO 762928 A NO762928 A NO 762928A NO 762928 A NO762928 A NO 762928A NO 143316 C NO143316 C NO 143316C
Authority
NO
Norway
Prior art keywords
oxsazolidinons
preparation
new
pharmacodynamic properties
analogy procedure
Prior art date
Application number
NO762928A
Other languages
English (en)
Norwegian (no)
Other versions
NO143316B (no
NO762928L (sv
Inventor
Friedrich-Gero Koellensperger
York Hartleben
Rolf Kretzschmar
Bernhard Neteler
Original Assignee
Nordmark Werke Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordmark Werke Gmbh filed Critical Nordmark Werke Gmbh
Publication of NO762928L publication Critical patent/NO762928L/no
Publication of NO143316B publication Critical patent/NO143316B/no
Publication of NO143316C publication Critical patent/NO143316C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO762928A 1975-08-29 1976-08-25 Analogifremgangsmaate til fremstilling av ny oksazolidinoner med farmakodynamiske egenskaper NO143316C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2538424A DE2538424C2 (de) 1975-08-29 1975-08-29 4-substituierte 5-Phenyl-oxazolidon-(2)- Verbindungen und ein diese enthaltendes pharmazeutisches Präparat

Publications (3)

Publication Number Publication Date
NO762928L NO762928L (sv) 1977-03-01
NO143316B NO143316B (no) 1980-10-06
NO143316C true NO143316C (no) 1981-01-14

Family

ID=5955093

Family Applications (1)

Application Number Title Priority Date Filing Date
NO762928A NO143316C (no) 1975-08-29 1976-08-25 Analogifremgangsmaate til fremstilling av ny oksazolidinoner med farmakodynamiske egenskaper

Country Status (22)

Country Link
US (1) US4139538A (sv)
JP (1) JPS5253857A (sv)
AT (1) AT347453B (sv)
AU (1) AU506441B2 (sv)
BE (1) BE845581A (sv)
CA (1) CA1072567A (sv)
CH (1) CH623043A5 (sv)
DE (1) DE2538424C2 (sv)
DK (1) DK387876A (sv)
FI (1) FI62074C (sv)
FR (1) FR2321884A1 (sv)
GB (1) GB1555658A (sv)
HU (1) HU174488B (sv)
IE (1) IE43396B1 (sv)
IL (1) IL50091A (sv)
IN (1) IN144061B (sv)
LU (1) LU75659A1 (sv)
NL (1) NL7609559A (sv)
NO (1) NO143316C (sv)
PL (1) PL100901B1 (sv)
SE (1) SE424991B (sv)
ZA (1) ZA764279B (sv)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179442A (en) * 1975-08-29 1979-12-18 York Hartleben 4-(Alpha-hydroxy-isopropyl)-5-phenyl-oxazolidin-2-one
LU80081A1 (fr) * 1977-08-26 1979-05-15 Delalande Sa Nouvelles hydroxymethyl-5 oxazolidinones-2,leur procede de preparation et leur application therapeutique
DE2961251D1 (en) * 1978-08-15 1982-01-14 Smithkline Beckman Corp A method of preparing a 2-hydroxy-3-isopropyl or a 2-hydroxy-3-tert-butylaminopropyl aromatic ether
US5105009A (en) * 1983-06-02 1992-04-14 Zambon S.P.A. Intermediates for the preparation of 1-(phenyl)-1-hydroxy-2-amino-3-fluoropropane derivatives
US5623087A (en) * 1995-03-10 1997-04-22 Ndsu-Research Foundation Method for preparation of optically active diarylalanines
GB9826700D0 (en) * 1998-12-05 1999-01-27 Univ Durham Process for preparing chiral compounds
WO2001074792A2 (en) * 2000-03-31 2001-10-11 Abbott Laboratories Process for the preparation of matrix metalloproteinase inhibitors
US20020019539A1 (en) 2000-03-31 2002-02-14 Bailey Anne E. Process for the preparation of matrix metalloproteinase inhibitors
FR2832613B1 (fr) * 2001-11-27 2004-02-13 Seb Sa Panier de cuisson d'aliments pour autocuiseur, autocuiseur destne a recevoir un panier de cuisson et procede de fabrication d'un panier de cuisson d'aliments par emboutissage
WO2008032191A2 (en) 2006-09-13 2008-03-20 Astrazeneca Ab Spiro-oxazolidinone compounds and their use as metabotropic glutamate receptor potentiators
WO2014067861A1 (en) * 2012-10-29 2014-05-08 F. Hoffmann-La Roche Ag 3,4-disubstituted oxazolidinone derivatives and their use as inhibitors of the calcium activated potassium channel

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1302662B (sv) * 1971-02-04
US2399118A (en) * 1942-02-13 1946-04-23 Mallinckrodt Chemical Works 2-oxazolidone compounds and method for preparing the same
DE1157627B (de) * 1957-08-28 1963-11-21 Robins Co Inc A H Verfahren zur Herstellung von 5-(o-Alkoxyphenoxymethyl)-oxazolidonen-(2)
DE1130131B (de) * 1957-11-08 1962-05-24 Eugen Bellmann G M B H Maschf Bundkippzange
BE585502A (fr) 1958-12-09 1960-06-09 American Cyanamid Co Composes hétérocycliques azotés et procéde pour leur préparation.
US3133932A (en) * 1959-05-25 1964-05-19 Deere & Co Production of 2-oxazolidinones
DE1198368B (de) * 1959-08-06 1965-08-12 Robins Co Inc A H Verfahren zur Herstellung von 5-(2, 6-Dimethoxyphenoxymethyl)-oxazolidon-(2)
DE1803180U (de) * 1959-11-05 1959-12-31 Wickmann Werke Ag Freiluft-isolator.
FR1274416A (fr) * 1959-12-09 1961-10-27 American Cyanamid Co Procédé de préparation de nouvelles aryloxyméthyl-2-oxazolidinones
US3450674A (en) * 1963-10-04 1969-06-17 Dow Chemical Co Poly-n-heterocyclics and method
GB1102011A (en) * 1964-05-21 1968-02-07 Richardson Merrell Spa Phenol esters of amino acids
NL129025C (sv) * 1965-04-29
US3538064A (en) * 1965-06-04 1970-11-03 Commercial Solvents Corp Acrylic acid esters of hydroxymethyl oxazolidones
GB1224995A (en) * 1968-09-20 1971-03-10 Delalande Sa New 5-propargyloxymethyl-2-substituted oxazolidinones and their process of preparation
GB1222708A (en) * 1968-10-22 1971-02-17 Delalande Sa Novel 5-(n-substituted aminomethyl)-2-oxazolidinones and their process of preparation
ZA71932B (en) * 1970-02-27 1971-10-27 Ici Ltd Organic compounds
BE763964A (fr) * 1970-03-24 1971-09-08 Delalande Sa Nouveaux derives de l'aminocarbonyl-3 oxazolidinone-2, leur procede de preparation et leur application en therapeutique
FR2179582B1 (sv) * 1972-04-13 1975-10-10 Synthelabo

Also Published As

Publication number Publication date
HU174488B (hu) 1980-01-28
JPS5253857A (en) 1977-04-30
CA1072567A (en) 1980-02-26
FR2321884A1 (fr) 1977-03-25
SE424991B (sv) 1982-08-23
AU506441B2 (en) 1980-01-03
IN144061B (sv) 1978-03-18
FR2321884B1 (sv) 1979-03-23
AT347453B (de) 1978-12-27
DK387876A (da) 1977-03-01
IE43396L (en) 1977-02-28
PL100901B1 (pl) 1978-11-30
US4139538A (en) 1979-02-13
JPS564554B2 (sv) 1981-01-30
IL50091A0 (en) 1976-09-30
IL50091A (en) 1981-01-30
AU1614576A (en) 1978-01-26
CH623043A5 (sv) 1981-05-15
BE845581A (fr) 1976-12-16
ZA764279B (en) 1977-07-27
LU75659A1 (sv) 1977-03-31
IE43396B1 (en) 1981-02-11
FI62074B (fi) 1982-07-30
NO143316B (no) 1980-10-06
FI62074C (fi) 1982-11-10
NO762928L (sv) 1977-03-01
DE2538424C2 (de) 1983-01-05
GB1555658A (en) 1979-11-14
ATA619876A (de) 1978-05-15
DE2538424A1 (de) 1977-03-03
SE7609426L (sv) 1977-03-01
NL7609559A (nl) 1977-03-02
FI762400A (sv) 1977-03-01

Similar Documents

Publication Publication Date Title
SE433208B (sv) Forfarande for framstellning av fenoletrar
DK148907C (da) Analogifremgangsmaade til fremstilling af dihydrocyclosporin c
SE435059B (sv) Forfarande for framstellning av med kveveheterocykliska grupper substituerade 1-fenyl-2-alkylaminoetanol-foreningar
DK149107C (da) Analogifremgangsmaade til fremstilling af quinazolonderivater
DK146205C (da) Analogifremgangsmaade til fremstilling af 8alfa-ergolin-i-derivater
SE7605139L (sv) Forfarande for framstellning av vattenupptagande cellulosaetrar
SE430336B (sv) Forbettrat forfarande for framstellning av amoxicillinfrihydrat
DK107876A (da) Fremgangsmade til fremstilling af thiocarbamider
NO143316C (no) Analogifremgangsmaate til fremstilling av ny oksazolidinoner med farmakodynamiske egenskaper
DK148139C (da) Analogifremgangsmaade til fremstilling af 5-benzyl-2-oxazolidonderivater
DK150676A (da) Fremgangsmade til fremstilling af krystallinsk natrium-o-formyl-cefamandol
SE427839B (sv) Analogiforfaranden for framstellning av n-aryl-n-(1-l-4-piperidinyl)-aryl-acetamider
SE419983B (sv) Forfarande for framstellning av finkornig, fast cyanurklorid
NO146058C (no) Analogifremgangsmaate for fremstilling av substituerte benzamider
SE434263B (sv) Forfarande for framstellning av kloretylnitrosokarbamider med antitumorverkan
DK146629C (da) Analogifremgangsmaade til fremstilling af depotsteroidestere
SE7606116L (sv) Forfarande for framstellning av 3-fenoxidbensaldehyder
SE7604781L (sv) Forfarande for framstellning av diarylhydroxibutylaminer
SE427841B (sv) Analogiforfarande for framstellning av tienamycinderivat
SE421793B (sv) Analogiforfarande for framstellning naftyridinsubstituerade pyrrolderivat
NO143314C (no) Fremgangsmaate for fremstilling av akrylamid
SE7600847L (sv) Nytt forfarande for framstellning av 8-bromtienotriazolo-1,4-diazepiner
SE446726B (sv) Forfarande for framstellning av 16-metoxiprostaglandiner
SE7610637L (sv) Forfarande for framstellning av 2-alkylindaner
DK366676A (da) Fremgangsmade til fremstilling af slagseje polyvinylaromater